To test whether certain ABCB1 haplotypes contribute to interindividual differences in central nervous system drug distribution , brain distribution of a model P-glycoprotein substrate , the calcium channel inhibitor verapamil , was measured by positron emission tomography ( PET ) in 2 groups of healthy volunteers .